These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6810677)

  • 21. Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Larsson SG; Wide L
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):333-8. PubMed ID: 7293665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid size reduction of giant prolactinoma following medical treatment.
    Perani D; Colombo N; Scotti G; Tonon C
    J Comput Assist Tomogr; 1984 Feb; 8(1):131-3. PubMed ID: 6690496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term bromocriptine treatment for prolactin-secreting macroadenoma.
    Huseman CA; Rizk G; Hahn F
    Am J Dis Child; 1986 Dec; 140(12):1216-7. PubMed ID: 3776935
    [No Abstract]   [Full Text] [Related]  

  • 24. Discordant responses of prolactinoma to two different dopamine agonists.
    Ahmed SR; Shalet SM
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):421-6. PubMed ID: 3742834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of preoperative bromocriptine therapy on success of surgery for microprolactinoma.
    Fahlbusch R; Buchfelder M; Rjosk HK; von Werder K
    Lancet; 1984 Sep; 2(8401):520. PubMed ID: 6147577
    [No Abstract]   [Full Text] [Related]  

  • 27. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
    Sadoul JL; Thyss A; Freychet P
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography.
    Johnston DG; Hall K; Kendall-Taylor P; Ross WM; Crombie AL; Cook DB; Watson MJ
    Clin Endocrinol (Oxf); 1986 Jun; 24(6):675-85. PubMed ID: 3098457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary tumours: surgery or medical shrinkage.
    Grossman A
    Practitioner; 1986 Sep; 230(1419):809-10. PubMed ID: 3809102
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolactin secreting pituitary carcinoma.
    Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent prolactinoma and meningioma following irradiation and bromocriptine treatment.
    Kolodny J; Dluhy RG
    Am J Med; 1985 Jan; 78(1):153-5. PubMed ID: 3966480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.
    Bevan JS; Adams CB; Burke CW; Morton KE; Molyneux AJ; Moore RA; Esiri MM
    Clin Endocrinol (Oxf); 1987 May; 26(5):541-56. PubMed ID: 3665118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complete regression of prolactin-secreting pituitary tumors by bromocriptine therapy (author's transl)].
    Munemitsu H; Matsuda M; Hirai O; Kawamura J; Matsubayashi K; Fukuyama H
    No Shinkei Geka; 1980 Oct; 8(10):981-6. PubMed ID: 7442930
    [No Abstract]   [Full Text] [Related]  

  • 34. Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
    Verde G; Loli P; Berselli ME; Tagliaferri M; Dallabonzana D; Oppizzi G; Liuzzi A; Chiodini PG; Luccarelli G; Lodrini S
    J Endocrinol Invest; 1984 Feb; 7(1):51-4. PubMed ID: 6715796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual function in prolactinoma patients treated with bromocriptine.
    Moster ML; Savino PJ; Schatz NJ; Snyder PJ; Sergott RC; Bosley TM
    Ophthalmology; 1985 Oct; 92(10):1332-41. PubMed ID: 4069600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth and puberty arrest due to prolactinoma.
    Sack J; Friedman E; Tadmor R; Sahar A; Katznelson D
    Acta Paediatr Scand; 1984 Nov; 73(6):863-7. PubMed ID: 6524373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
    Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
    Br J Obstet Gynaecol; 1980 Jun; 87(6):523-9. PubMed ID: 7397087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma.
    Holness RO; Shlossberg AH; Heffernan LP
    Neurology; 1984 Jan; 34(1):111-3. PubMed ID: 6537833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine treatment of prolactin secreting macroadenomas: a radiological, ophthalmological and endocrinological study.
    van 't Verlaat JW; Croughs RJ; Hendriks MJ; Bosma NJ; Nortier JW; Thijssen JH
    Acta Endocrinol (Copenh); 1986 Aug; 112(4):487-93. PubMed ID: 3751462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours.
    Benker G; Gieshoff B; Freundlieb O; Windeck R; Schulte HM; Lancranjan I; Reinwein D
    Clin Endocrinol (Oxf); 1986 May; 24(5):505-13. PubMed ID: 3791649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.